COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BISPECIFIC MOLECULES

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON

Treatment of cancer with anti-GITR agonist antibodies

ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

AntiPlexin A1 agonist antibody

Bispecific antibodies against HER2 and CD3

Anti-coagulation factor XI antibodies

Vectors comprising nucleic acids encoding anti-OX40 antibodies

Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

Anti-coagulation factor XI antibodies

B7-H4 antibodies and methods of use thereof

HUMAN IMMUNE THERAPIES USING A CD27 AGONIST ALONE OR IN COMBINATION WITH OTHER IMMUNE MODULATORS

Humanized antibodies with ultralong complementary determining regions

Fn14 Binding Proteins and Uses Thereof

AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF

Agonistic CD40 antibodies

BTLA agonist antibodies and uses thereof

Humanized monoclonal antibodies that target VE-PTP (HPTP-β)

TREATMENT OF OCULAR DISEASE

FC engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them

Antagonists targeting the TGF-β pathway

Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

Markers of acute myeloid leukemia stem cells

Adenovirus armed with bispecific T cell activator

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

Anti-TLR4 antibodies and uses thereof

Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody

Trifunctional molecule and application thereof

IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR (V-R) AND USE THEREOF TO PRODUCE VISTA/VSIG8 AGONISTS AND ANTAGONISTS

PDL1-binding proteins

WNT SIGNALING AGONIST MOLECULES

WNT SIGNALING AGONIST MOLECULES

Tumor-targeted agonistic CD28 antigen binding molecules

Humanized or chimeric CD3 antibodies

COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST

Polypeptides

Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)

COMBINATION THERAPY WITH ICOS AGONIST AND OX40 AGONIST TO TREAT CANCER

COMBINATION THERAPY

Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use

Anti-PD-1 antibodies

INTERLEUKIN-2 IMMUNOCONJUGATE, A CD40 AGONIST, AND OPTIONALLY A PD-1 AXIS BINDING ANTAGONIST FOR USE IN METHODS OF TREATING CANCER

Binding molecule activating FXII

ANTI-OX40 ANTIBODIES AND THEIR USES

Polypeptide variants and uses thereof

Anti-human 4-1BB antibodies and uses thereof

LIVE AND IN-VIVO TUMOR SPECIFIC CANCER VACCINE SYSTEM DEVELOPED BY CO-ADMINISTRATION OF EITHER AT LEAST TWO OR ALL THREE OF THE FOLLOWING COMPONENTS SUCH AS TUMOR CELLS, AN ONCOLYTIC VIRUS VECTOR WITH TRANSGENIC EXPRESSION OF GM-CSF AND AN IMMUNE CHECKPOINT MODULATOR

CD123 binding proteins and related compositions and methods

Binding agonist for treatment of neurological and other disorders

Bispecific antibodies which bind PD-L1 and GITR

Resolvin mimetic antibodies and uses thereof

METHODS AND COMPOSITIONS FOR LIGAND DIRECTED ANTIBODY DESIGN

Anti-ALK antibodies and methods for use thereof

Anti-CD137 antibodies

Bispecific antibodies for factor IX and factor X

MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH

Inducible monovalent antigen binding protein

Oncolytic virus and method

Anti-OX40 antibody and use thereof

TREM2 stabilizing antibodies

Anti-claudin-2 monoclonal antibody

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Humanized antibodies

FcgammaRIIB-Specific Antibodies and Methods of Use Thereof

Anti-TREM1 antibodies and methods of use thereof

MEDICAL TREATMENT METHOD WITH ADMINISTRATION OF DENDRITIC CELLS

PD-L1 expressing hematopoietic stem cells and uses

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

Anti-NPR1 antibodies and uses thereof

BISPECIFIC ANTIBODIES

ICOS binding proteins

Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Single domain antibodies targeting CD1d

Anti-CD3 antibodies

Antibodies specific for hyperphosphorylated tau and methods of use thereof

NOTCH3 agonist compositions and methods for treating small vessel diseases

Anti-IL1RAP antibodies

ANTIBODY HEAVY CHAIN VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

Anti-TIGIT antigen-binding proteins and methods of use thereof

Targeted chimeric proteins and uses thereof

HUMANIZED ANTI-CD40 ANTIBODIES

CD200R agonist antibodies and uses thereof

Vista modulators for diagnosis and treatment of cancer

PD-L1 expressing hematopoietic stem cells and uses

T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOF

Agonistic tumor necrosis factor (TNF) receptor binding agents

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies and methods of use thereof

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

Anti-LAG-3 antibodies and uses thereof

Anti-LILRB3 antibodies and methods of use thereof

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

Anti-transferrin receptor antibodies with tailored affinity

Antigen binding molecules and methods of use thereof

Anti-OX40 antibodies and their uses

BISPECIFIC ANTIBODY AGAINST OX40 AND CTLA-4

Tissue-specific Wnt signal enhancing molecules and uses thereof

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

Anti-PD-1 antibodies and their uses

Anti-CD40 antibodies

Drug delivery compositions and uses thereof

Anti-ICOS agonist antibodies and uses thereof

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

PROTEINS BINDING PSMA, NKG2D AND CD16

COMPOSITIONS AND METHODS FOR MODULATING CELL SIGNALING

MONOCLONAL ANTIBODIES ACTIVATING CD40 AND USES THEREOF

Binding molecules that bind CD137 and PD-L1

IMMUNOMODULATORY ANTIBODIES

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

Anti-vista antibodies and fragments

B7-DC BINDING ANTIBODY

Anti-CD40 antibody

Dysfunctional antigen-specific CD8T cells in the tumor microenvironment

Compositions and methods for treating cancer

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

Oncofetal antigen binding proteins and related compositions and methods

Drug delivery compositions and uses thereof

Fusion Polypeptides Capable Of Activating Receptors

BINDING AGENTS

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

Anti-OX40 antibodies and anti-GITR antibodies

TRAILshort antibody and methods of use

Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist

DISTINGUISHING ANTAGONISTIC AND AGONISTIC ANTI B7-H1 ANTIBODIES

CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF

ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII

Anti-SIRPA antibodies and methods of use thereof

Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies

Antagonizing CD73 antibody

Anti-CD137 antibodies and uses thereof

Anti-CD137 antibodies and uses thereof

Nucleic acids encoding anti-OX40 antibodies

Antibodies directed against ICOS and uses thereof

NOVEL IGFR_LIKE 2 RECEPTOR AND USES THEREOF

MULTIMERIC CD40 BINDING MOLECULES AND USES THEREOF

MULTIMERIC CD137/4-1BB BINDING MOLECULES AND USES THEREOF

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

MULTIMERIC OX40 BINDING MOLECULES AND USES THEREOF

MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES

IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof

Anti-FGFR3 antibodies and methods using same

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

Anti-human VISTA antibodies and use thereof

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Methods for cancer therapy using isolated NTB-A ectodomain polypeptides

Agonistic antibodies that bind CD40

MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE HAVING ALTERNATIVE FUNCTION TO FUNCTION OF BLOOD COAGULATION FACTOR VIII

Anti-DR5 antibodies and methods of use thereof

Anti-MET antibodies and uses thereof

Methods of treatment using anti-c-met antibodies

Anti-TIGIT antibodies

Antibodies directed against ICOS and uses thereof

Anti-TREM2 antibodies and methods of use thereof

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

Anti-GITR antibodies and methods of use thereof

Methods of treatment using a leptin receptor agonist antibody

Anti-ICOS agonist antibodies and uses thereof

4-1BB binding proteins and uses thereof

Anti-OX40 antibodies

Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Anti-TIE2 antibodies and uses thereof

Antigen-binding polypeptides directed against CD38

POLYPEPTIDE VARIANTS AND USES THEREOF

Anti-TIM-3 antibodies and compositions

Anti-SIRP-alpha antibodies and methods of use thereof

PD-1 agonist antibodies and uses thereof

Methods of treating an IGFBP-3R expressing cancer using anti-IGFBP-3R antibodies

Agonist antibodies that bind human CD137 and uses thereof

Sequence of antibody heavy chain constant region for enhancing agonistic antibody activity

Multivalent and multispecific OX40-binding fusion proteins

Immunoglobulins binding human Vγ9Vδ2 T cell receptors

Dual receptor antagonistic antigen-binding proteins and uses thereof

Anti-ICOS and anti-PD-1 antibody combination therapy

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Nucleic acids encoding an anti-CD40 antibody

Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor

Anti-MERTK agonistic antibodies and uses thereof

Adenovirus armed with bispecific T cell engager

IFN-γ-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof

Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators

Non-cytotoxic modified cells and use thereof

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Anti-LAG-3 antibodies and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Platforms and methods for optimizing host antigen presentation and host antitumor and antipathogen immunity

Anti-PD-L1 antibodies and methods of use

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

Humanized Anti-CD134 (OX40) Antibodies And Uses Thereof

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

Antibodies for Siglec-15 and methods of use thereof

Anti-CD277 antibodies

Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager

Anti-4-1BB antibodies and their uses

Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy

Methods of treating autoimmune disease or chronic inflammation with antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof

Broadly cross-reactive HIV-1-specific antibodies for prevention and treatment of HIV

Retroviral and lentiviral vectors

Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production

Anti-OX40 binding proteins

TrkB agonist antibodies and methods for treating an ocular degenerative disorder characterized by degeneration of retinal ganglion cells (RGCs)

Fusion protein comprising apelin and an anti-APLNR antibody

Anti-ICOS agonist antibodies and uses thereof

NOVEL BISPECIFIC POLYPEPTIDES AGAINST CD137

CANCER AND B-CELL RELATED DISEASE THERAPY

COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND TIGIT INHIBITORS

Variant antibodies that bind OX40

Therapeutic combinations comprising anti-FOLR1 immunoconjugates

Bispecific Antibodies Directed Against OX40 and a Tumor-Associated Antigen

Antibody therapeutics that bind CD137

Anti-TrkB monoclonal antibodies and methods of use

SP35 Antibodies And Uses Thereof

Anti-LAG-3 antibodies

Drug delivery compositions and uses thereof

Heterodimeric immunoglobulins

RNA containing composition for treatment of tumor diseases

REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF

ANTI-DR5 ANTIBODIES AND METHODS OF USE THEREOF

C3D cellular and acellular vaccines for the prevention and treatment of cancer

Combining CD27 agonists and immune checkpoint inhibition for immune stimulation

AGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 ANTIBODIES

Anti-SIRPa antibodies and their therapeutic applications

THERAPEUTIC AGENT FOR SOLID CANCER

Methods for selective expansion of γδ T-cell populations and compositions thereof

Compositions and methods for treating pancreatitis and pain with death receptor agonists

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

T cell recruiting polypeptides based on TCR alpha/beta reactivity

ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

IL-21 agonist antibodies and methods of treatment using same

Methods Of Identifying Anti-Inflammatory Compounds

Immunological reagents

Beta klotho-binding proteins and methods of use thereof

Anti-OX40 antibodies and methods of using the same

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

PD-L1 expressing hematopoietic stem cells and uses

STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY

B7-H4 antibodies and methods of use thereof

Method of treating cancer with a biomaterial and a toll-like receptor agonist

Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP)

Antiviral immunotherapy by membrane receptor ligation

Anti-ICOS agonist antibodies and uses thereof

Compositions and methods for regulating erythropoiesis

Methods of treatment of CD123 overexpressing disorders

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

Anti-human 4-1BB antibodies and uses thereof

Nucleic acid molecules encoding anti-CD40 antibodies

Humanized Anti-HLA-DR Antibodies

Methods of treating cancer using an IL-21 agonist

Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors

Antibodies specific for DR5 and methods of use

Anti-GITR antibodies and methods of use thereof

FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB

COMBINATION THERAPY COMPRISING ANTI-ANGIOGENESIS AGENTS AND OX40 BINDING AGONISTS

Highly potent antibodies binding to death receptor 4

Immunological reagents

Anti-Siglec-9 antibodies and methods of use thereof

Fc γ RIII binding fibronectin type III domains, their conjugates and multispecific molecules comprising them

Agonist antibodies that bind human CD137 and uses thereof

Multispecific NK engager protein

Anti-CD137 molecules and use thereof

RNA containing composition for treatment of tumor diseases

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

Multispecific NK engager protein

Engineered antibody Fc variants for enhanced serum half life

Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

FGF21 mimetic antibodies and uses thereof

METHODS OF SCREENING FOR MULTISPECIFIC ANTIBODIES

Anti-TREM2 antibodies and methods of use thereof

Compositions and methods for detecting, treating and preventing diseases and disorders

COMBINATION OF AN OX40 AGONIST AND A 4-1BB AGONIST MONOCLONAL ANTIBODY FOR TREATING CANCER

Combination Therapies Employing GITR Binding Molecules

Therapeutic and diagnostic methods for autism spectrum disorders and other conditions

Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies

ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF

Oncofetal antigen binding proteins and related compositions and methods

Antibodies binding LAG-3 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Targeting WSB1 and pVHL to treat cancer

Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

Binding agents

Anti-GITR antibodies and methods of use thereof

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF